Shivalik Rasayan Ltd

Shivalik Rasayan Ltd

₹ 579 -1.80%
24 May - close price
About

The company is into manufacturing of agrochemicals and in 2015 it forayed into pharmaceuticals.
The company acquired Medicamen Biotech Limited in 2015 which is engaged in manufacturing pharmaceutical formulations. [1] [2]

Key Points

Business Segments
Shivalik Rasayan is into 2 business segments :

  • Market Cap 901 Cr.
  • Current Price 579
  • High / Low 893 / 493
  • Stock P/E 72.5
  • Book Value 238
  • Dividend Yield 0.09 %
  • ROCE 8.30 %
  • ROE 6.56 %
  • Face Value 5.00

Pros

Cons

  • The company has delivered a poor sales growth of 8.61% over past five years.
  • Company has a low return on equity of 8.77% over last 3 years.
  • Dividend payout has been low at 3.38% of profits over last 3 years
  • Promoter holding has decreased over last 3 years: -4.97%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
55.85 43.32 50.39 56.69 59.53 48.14 57.83 56.33 57.36 62.93 64.47 67.05 70.23
44.18 32.36 37.86 44.69 47.60 37.84 45.99 45.32 47.38 52.81 53.10 57.39 61.37
Operating Profit 11.67 10.96 12.53 12.00 11.93 10.30 11.84 11.01 9.98 10.12 11.37 9.66 8.86
OPM % 20.90% 25.30% 24.87% 21.17% 20.04% 21.40% 20.47% 19.55% 17.40% 16.08% 17.64% 14.41% 12.62%
0.23 0.55 0.08 0.48 1.30 1.85 1.45 0.85 1.46 0.90 0.42 0.56 1.50
Interest 0.27 0.50 0.36 0.52 0.74 0.89 1.03 0.88 1.07 1.36 1.47 1.96 1.58
Depreciation 3.03 2.11 2.60 2.64 2.92 2.85 3.01 2.83 2.95 2.81 2.81 3.44 3.01
Profit before tax 8.60 8.90 9.65 9.32 9.57 8.41 9.25 8.15 7.42 6.85 7.51 4.82 5.77
Tax % 16.16% 4.49% 5.28% 7.62% 12.64% 3.09% 8.54% 6.26% 10.24% -3.21% 13.72% 45.02% 24.78%
7.20 8.50 9.14 8.61 8.37 8.14 8.46 7.65 6.65 7.08 6.48 2.65 4.34
EPS in Rs 3.90 4.77 4.88 4.44 4.28 4.51 4.40 3.82 3.27 2.28 2.80 1.21 1.97
Raw PDF
Upcoming result date: 29 May 2024

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
41 110 123 155 171 186 198 215 234 265
38 99 105 131 147 157 159 167 191 225
Operating Profit 3 10 18 24 24 29 38 47 43 40
OPM % 7% 9% 15% 16% 14% 16% 19% 22% 19% 15%
0 1 1 3 8 3 1 4 5 3
Interest 0 5 6 4 3 2 2 3 5 6
Depreciation 0 2 2 2 3 4 9 11 12 12
Profit before tax 3 5 11 20 26 27 29 37 32 25
Tax % 33% 33% 25% 25% 20% 17% 15% 7% 6%
2 3 8 15 21 22 25 34 30 21
EPS in Rs 2.10 3.66 9.84 14.39 9.88 10.17 12.77 17.68 14.66 8.26
Dividend Payout % 0% 0% 4% 3% 5% 2% 4% 3% 3%
Compounded Sales Growth
10 Years: %
5 Years: 9%
3 Years: 8%
TTM: 21%
Compounded Profit Growth
10 Years: %
5 Years: 7%
3 Years: 15%
TTM: -46%
Stock Price CAGR
10 Years: %
5 Years: 16%
3 Years: -8%
1 Year: -20%
Return on Equity
10 Years: %
5 Years: 9%
3 Years: 9%
Last Year: 7%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 3 3 3 4 7 7 7 7 7 8
Reserves 8 11 7 45 158 169 172 280 353 362
0 31 32 22 20 10 29 38 58 63
11 36 52 81 103 142 155 163 160 245
Total Liabilities 23 81 94 152 288 328 363 488 578 677
7 27 27 40 41 52 210 221 218 217
CWIP 0 0 0 0 26 102 0 3 57 79
Investments 0 0 0 0 0 0 0 0 0 0
16 53 66 111 222 175 153 264 303 381
Total Assets 23 81 94 152 288 328 363 488 578 677

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
4 12 8 -7 -8 6 59 11 -19
-0 -18 -4 -24 -24 -102 -65 -23 -71
1 3 -3 52 100 10 2 78 50
Net Cash Flow 4 -3 2 21 69 -86 -4 66 -40

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 80 77 92 108 111 114 127 119 132
Inventory Days 5 64 76 65 71 65 34 148 239
Days Payable 126 152 137 103 123 171 152 216 208
Cash Conversion Cycle -41 -11 31 71 59 7 9 51 162
Working Capital Days -11 36 52 107 147 160 98 146 206
ROCE % 32% 32% 28% 16% 11% 11% 12% 8%

Shareholding Pattern

Numbers in percentages

2 Recently
Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
52.92% 52.92% 50.32% 50.32% 50.32% 50.32% 50.32% 50.32% 50.05% 47.95% 47.95% 47.95%
0.00% 0.00% 0.00% 0.06% 0.04% 0.01% 0.01% 0.01% 0.35% 0.66% 1.18% 2.99%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.24% 0.59% 0.88%
47.08% 47.08% 49.68% 49.62% 49.64% 49.67% 49.67% 49.67% 49.60% 51.14% 50.28% 48.17%
No. of Shareholders 6,1997,4017,7907,7927,7268,3808,5798,4608,5569,1909,1499,398

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents